AgelessRx

Industry · 10 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	Combination Gerotherapeutic Interventions for Healthspan Improvement Healthspan Improvement, Aging, Longevity	Phase 3	2025-07-23
Recruiting	Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation Longevity, GLP-1, Geroscience	Phase 2 / Phase 3	2024-12-17
Enrolling By Invitation	Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures Longevity, Quality of Life, Mood	EARLY_Phase 1	2024-11-01
Completed	The Efficacy and Tolerability of Canagliflozin in Healthy Individual Healthy Aging	Phase 4	2024-02-12
Completed	The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals Aging	—	2023-04-25
Completed	The Efficacy and Tolerability of Acarbose in Healthy Individuals Tolerance, Side Effect, Glucose Response	Phase 4	2022-08-10
Withdrawn	The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging Aging	—	2022-03-14
Withdrawn	Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 Covid19	Phase 2	2021-02-01
Completed	Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome Covid19, Long COVID-19, Post-COVID-19 Syndrome	Phase 2	2021-01-28
Completed	Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study Aging	Phase 2	2020-01-01